Skip to main content
NCBI home page
Gut logoLink to Gut
. 1981 Jan;22(1):8–13. doi: 10.1136/gut.22.1.8

In vitro and in vivo analysis of the PABA test compared with the Lundh test--influence of intraluminal pH.

F J Hoek, G T Sanders, A Teunen, G N Tijtgat
PMCID: PMC1419314  PMID: 6970154

Abstract

Lundh test and PABA test results were compared in 50 patients. In the resulting correlation curve three areas of interest were differentiated: (1) an area with mean tryptic activity, found in the Lundh test, below 4 U/ml, where an abnormal PABA test result was also seen; (2) an intermediate area from 4 to 9 U/ml, where PABA test results may be found in discordance with the Lundh test; (3) the normal level, where PABA excretion was shown to be independent of intestinal chymotrypsin activity. In experiments in vitro on the kinetics of the hydrolysis of BTPABA by chymotrypsin the profound influence of the pH on Km and Vmax was shown. This influence of the pH explains why in the intermediate area of pancreatic dysfunction normal PABA test results were found in a number of cases. A higher mean pH level of the Lundh test aspirates was found for patients with a normal PABA test result than for patients with an abnormal PABA test.

Full text

PDF
8

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arvanitakis C., Greenberger N. J. Diagnosis of pancreatic disease by a synthetic peptide. A new test of exocrine pancreatic function. Lancet. 1976 Mar 27;1(7961):663–666. doi: 10.1016/s0140-6736(76)92777-x. [DOI] [PubMed] [Google Scholar]
  2. Bornschein W. Der Peptid-PABA-Test Methodische und klinische Untersuchungen mit einem neuen indirekten Pankreasfunktionstest. Fortschr Med. 1977 Nov 10;95(42):2559–2564. [PubMed] [Google Scholar]
  3. Bornschein W., Goldmann F. L., Dressler J. Diagnostik der exokrinen Pankreasinsuffizienz mit einem synthetischen chymotrypsinspezifischen Peptid. Klin Wochenschr. 1978 Feb 15;56(4):197–205. doi: 10.1007/BF01705383. [DOI] [PubMed] [Google Scholar]
  4. Bühler H., Ammann R. PABA-Test versus Chymotrypsin- und Fettbestimmung im Stuhl in der Pankreasfunktionsdiagnostik. Schweiz Med Wochenschr. 1979 Apr 21;109(16):597–598. [PubMed] [Google Scholar]
  5. Cook H. B., Lennard-Jones J. E., Sherif S. M., Wiggins H. S. Measurement of tryptic activity in intestinal juice as a diagnostic test of pancreatic disease. Gut. 1967 Aug;8(4):408–414. doi: 10.1136/gut.8.4.408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DRUCKER M. M., BLONDHEIM S. H., WISLICKI L. FACTORS AFFECTING ACETYLATION IN-VIVO OF PARA-AMINOBENZOIC ACID BY HUMAN SUBJECTS. Clin Sci. 1964 Aug;27:133–141. [PubMed] [Google Scholar]
  7. Gyr K., Stalder G. A., Schiffmann I., Fehr C., Vonderschmitt D., Fahrlaender H. Oral administration of a chymotrypsin-labile peptide--a new test of exocrine pancreatic function in man (PFT). Gut. 1976 Jan;17(1):27–32. doi: 10.1136/gut.17.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harada H., Mishima K., Shundo T., Yamamoto N., Sasaki T., Hinofuji T., Hayashi T., Uchida Y., Kimura I. Exocrine pancreatic function test by a synthetic peptide. Am J Gastroenterol. 1979 Jan;71(1):45–52. [PubMed] [Google Scholar]
  9. Imamura K., Nakamura T., Miyazawa T., Abe Y., Kobayashi M., Takebe K., Toyota T. Oral administration of chymotrypsin labile peptide for a new test of exocrine pancreatic function (PET) in comparison and pancreozymin-secretin test. Am J Gastroenterol. 1978 May;69(5):572–578. [PubMed] [Google Scholar]
  10. Imondi A. R., Stradley R. P., Butler E. R., Wolgemuth R. L. A method for the assay of chymotrypsin in crude biological materials. Anal Biochem. 1973 Jul;54(1):199–204. doi: 10.1016/0003-2697(73)90263-7. [DOI] [PubMed] [Google Scholar]
  11. Imondi A. R., Stradley R. P., Wolgemuth R. Synthetic peptides in the diagnosis of exocrine pancreatic insufficiency in animals. Gut. 1972 Sep;13(9):726–731. doi: 10.1136/gut.13.9.726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Nousia-Arvanitakis S., Arvanitakis C., Desai N., Greenberger N. J. Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by the synthetic peptide N-benzoyl-L-tyrosyl-p-aminobenzoic acid. J Pediatr. 1978 May;92(5):734–737. doi: 10.1016/s0022-3476(78)80139-5. [DOI] [PubMed] [Google Scholar]
  13. Sacher M., Kobsa A., Shmerling D. H. PABA screening test for exocrine pancreatic function in infants and children. Arch Dis Child. 1978 Aug;53(8):639–641. doi: 10.1136/adc.53.8.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Thienhaus R., Niederau C. Die Untersuchung der exokrinen Pankreasfunktion mit N-Benzoyl-L-Tyrosyl-p-Aminobenzoesaüre. Z Gastroenterol. 1979 Mar;17(3):187–194. [PubMed] [Google Scholar]
  15. Wiggins H. S. Simple method for estimating trypsin. Gut. 1967 Aug;8(4):415–416. doi: 10.1136/gut.8.4.415. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES